Kinnjiu Biopharma Initiates Global Phase I Study for Exarafenib
Shanghai-based Kinnjiu Biopharma Inc. has announced the first subject dosing in the global multi-center Phase...
Clinical trial approval / initiation
Innovent Biologics Begins Phase I Trial for IBI333 in Neovascular AMD
China-based Innovent Biologics, Inc. (HKG: 1801) has announced the first subject dosing in a Phase...
Hybio’s COVID-19 Nasal Spray HY3000 Gets FDA Clinical Trial Approval
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) has announced receiving tacit clinical trial approval from...
Accutar Biotech Begins Phase I Trial for AC0176 in China
New Jersey-based Accutar Biotechnology Inc., which is heavily backed by Chinese funds, has announced the...
Grand Pharma’s First-in-Class RDC ITM-11 Accepted for IND Review
China-based Grand Pharmaceutical Group Ltd (HKG: 0512) has announced that an Investigational New Drug (IND)...
Mabwell’s IL-11 Monoclonal Antibody 9MW3811 Approved for Australian Clinical Trial
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced receiving clinical trial approval from...
InnoCare and Keymed Announce First Dosing of ICP-B05 Clinical Study
China-based firms InnoCare Pharma (HKG: 9969, SHA: 688428) and Keymed Biosciences (HKG: 2162) have jointly...
Luye Pharma’s Paliperidone Palmitate Approved for European Clinical Trials
China-based Luye Pharma Group (HKG: 2186) has announced receiving clinical trial approval in Europe for...
Abbisko’s ABSK121 Greenlit for Phase I Clinical Study by NMPA
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced receiving the go-ahead from the...
Shanghai Pharmaceuticals’ WST01 Receives FDA Clinical Clearance
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has announced receiving clinical clearance from the...
Neurophth’s NR082 Gene Therapy Completes Phase III Enrollment
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced the completion of all-patient enrollment and...
Insilico Medicine’s COVID-19 Drug ISM3312 Enters Clinical Trials
China-based AI-powered drug discovery firm Insilico Medicine has announced that its ISM3312, an oral COVID-19...
Chinagene Tech Initiates ZVS101e Gene Therapy Trial for Bietti’s Crystalline Dystrophy
Beijing-based Chinagene Tech, a specialist in hereditary ophthalmopathy diagnosis and gene therapy, has announced the...
Biosyngen’s BRG01 Gets FDA Nod for NPC Clinical Study
Cell and gene therapy (CGT) specialist Biosyngen Pte Ltd has announced receiving approval from the...
BRL Medicine Achieves First Cure of Thalassemia Major with BRL-101
Shanghai-based BRL Medicine Inc. has announced a significant breakthrough in the treatment of thalassemia major....
Immuno Cure BioTech Launches Phase I HIV/AIDS Vaccine Study
China-based Immuno Cure BioTech has announced the initiation of a Phase I clinical study for...
CSPC’s NBL-020 Gets NMPA Approval for Clinical Study in Advanced Solid Tumors
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced receiving the go-ahead from the National...
AIM Vaccine Gains Approvals for COVID-19 mRNA Vaccine Trials in Pakistan
China-based AIM Vaccine Co., Ltd (HKG: 6660) has announced receiving separate approvals in Pakistan to...
Innovent Biologics Initiates Phase III CLEAR Study for Picankibart in Psoriasis
China-based Innovent Biologics (HKG: 1801) has announced the first subject dosing in the Phase III...
Hengrui Pharmaceuticals Gains NMPA Approval for SHR-A1921 Clinical Study
Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced receiving the go-ahead from the National Medical Products...